Trending...
- California: Governor Newsom announces appointments 9.10.25 - 388
- John Thomas calls for unity and prayer after tragic loss - 355
- Ayurveda, Ayurvedic medical Science and Ayurvedic Therapies, Dr.Abhay Kumar Pati - 350
A one step, non-coupled, plate-based fluorometric assay for screening potential inhibitors of NNMT.
MILPITAS, Calif. - Californer -- Nicotinamide N-methyltransferase (NNMT; EC 2.1.1.1) is an important cytosolic enzyme. It catalyzes the N-methylation of nicotinamide by transferring a methyl group from S-adenosyl-L-methionine (SAM) to nicotinamide resulting in the formation of 1-methyl-nicotinamide (MNA) and S-adenosyl-L-homocysteine. NNMT plays a significant role in the regulation of metabolic pathways in tissues such as adipose and liver as well as in cancer cells. Abnormal NNMT expression and activity has been implicated in a number of chronic diseases including cardiovascular diseases, cancer, obestity, diabetes, osteoarthritis, Parkinson's disease etc. Therefore, small molecule inhibitors of NNMT could be beneficial in developing therapeutics for diseases characterized by abnormal NNMT activity.
More on The Californer
BioVision's Nicotinamide N-methyltransferase inhibitor screening Kit II is a non-coupled, plate-based fluorometric assay. The assay utilizes a selective NNMT substrate that is methylated by SAM to generate a fluorescent product, measured at Ex/Em = 320/420 nm. In the presence of 1-Methylnicotinamide, a NNMT inhibitor, the enzymatic activity is inhibited thereby resulting in a reduced fluorescent signal. The kit provids a one-step, rapid, reliable test for high-throughput screening of NNMT inhibitors.
Figures. a) NNMT enzyme activity in the presence or absence of MNA. b) NNMT enzyme activity in the presence or absence of DMSO. c) Inhibition of NNMT enzyme activity by MNA. IC50 of MNA was calculated as 25.45±2.5 μM. Assays were performed following the kit protocol.
For more information on this Assay kit Cat# K2081, Visit: https://bit.ly/3dfVWbW
More on The Californer
- LVN Jobs in LA Establishes Local Presence Offers In-Person Staffing Solutions for LA LVN Job Seekers
- Meet a Scientologist Tunes Up with Auto Expert Jimmy Alauria
- City of Long Beach Launches Second Cohort of Urban Planning and Design Internship Program
- California: Governor Newsom launches new statewide service effort to support the well-being of young men
- California: Governor, First Partner statement on the passing of Robert Redford
BioVision's Nicotinamide N-methyltransferase inhibitor screening Kit II is a non-coupled, plate-based fluorometric assay. The assay utilizes a selective NNMT substrate that is methylated by SAM to generate a fluorescent product, measured at Ex/Em = 320/420 nm. In the presence of 1-Methylnicotinamide, a NNMT inhibitor, the enzymatic activity is inhibited thereby resulting in a reduced fluorescent signal. The kit provids a one-step, rapid, reliable test for high-throughput screening of NNMT inhibitors.
Figures. a) NNMT enzyme activity in the presence or absence of MNA. b) NNMT enzyme activity in the presence or absence of DMSO. c) Inhibition of NNMT enzyme activity by MNA. IC50 of MNA was calculated as 25.45±2.5 μM. Assays were performed following the kit protocol.
For more information on this Assay kit Cat# K2081, Visit: https://bit.ly/3dfVWbW
Source: BioVision, Inc.
0 Comments
Latest on The Californer
- END WELL 2025 SUMMIT BRINGS "RADICAL BRAVERY" TO LOS ANGELES, FEATURING EMMA HEMING WILLIS AND YVETTE NICOLE BROWN AMONG LEADING VOICES IN END-OF-LIFE TRANSFORMATION
- Long Beach: City to Host Community Demo Day to Showcase Neighborhood Technology Solutions
- Sloan's Lake Dental Launches New Website to Enhance Patient Experience and Access to Modern Dental Care
- Upcoming River City Ball & Brawl Bundle Includes Kunio-kun's Basketball & Tournament Fighting
- Only 3 Weeks Left till the Start of the OpenSSL Conference 2025
- Sanguine Expands Oncology Biospecimen Offerings Through Strategic Clinic Partnerships
- ENTOUCH Completes $50 million Funding Round
- Teaming Agreement with Emtel Energy USA to Advance Thin-Film PV Energy Storage Capabilities; NASA agreements for Solar Space Tech; Ascent Solar $ASTI
- Nebuvex Acknowledges Platform "Too Secure" for Anonymous Traders; Institutional Investors Disagree
- From Tokyo to Berlin: FreeTo.Chat Unites Cultures with the World's First Confession VRX — EmojiStream™
- McKenzi Brooke Set to Electrify the Super Girl Surf Festival in Oceanside, California
- AZETHIO Launches Multi-Million Dollar User Protection Initiative Following Unprecedented Platform Growth
- Matecrypt Observes South American Cryptocurrency Adoption Surge Amid Economic Shifts
- Assent Uncovers Over 695 Unique PFAS Across Global Supply Chains as Regulations Increase
- Ascend in Motion Expands Flat-Rate Transfers from LAX to San Diego
- Cryptocurrency Quarterly Trading Volume Surpasses $15 Trillion Record High as BrazilNex Acknowledges Industry 'Growing Pains' Amid Market Speculation
- AHRFD Initiates Legal Proceedings Against Anwalt.de for Publishing Defamatory and False Content
- New Analysis Reveals the Complex Forces Driving the 'Great Human Reshuffle'
- AdamMoney Launches Nationwide Hiring for Remote Sales Representatives to Promote 1st of-Its-Kind Pr
- Elevate Unveils GroundComm X30 at 2025 International GSE Expo in Las Vegas